BioPorto (BIOPOR)

Currency in DKK
1.300
-0.006(-0.46%)
Closed·
BIOPOR Scorecard
Full Analysis
Quickly burning through cash
Earnings results expected in 5 days
BIOPOR is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
1.2901.340
52 wk Range
1.2002.495
Key Statistics
Prev. Close
1.306
Open
1.34
Day's Range
1.29-1.34
52 wk Range
1.2-2.495
Volume
129.14K
Average Volume (3m)
313.55K
1-Year Change
-47.15%
Book Value / Share
0.1
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
BIOPOR Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
4.000
Upside
+207.69%
Members' Sentiments
Bearish
Bullish
ProTips
Stock generally trades with low price volatility

BioPorto News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

BioPorto Company Profile

BioPorto A/S, an in-vitro diagnostics company, focuses on developing biomarker tests to help clinicians detect the onset of disease states for management and therapies in Europe, North America, Asia, and internationally. It offers ProNephro AKI (NGAL), a test for pediatric acute kidney injury (AKI); NGAL Test, a particle-enhanced turbidimetric immunoassay for the quantitative determination of neutrophil gelatinase-associated lipocalin (NGAL) in human urine, EDTA plasma, or heparin plasma on automated clinical chemistry analyzers to diagnose acute kidney injury; and antibodies to develop diagnostic immunoassays within disease areas, including immunodeficiency, allergy, coagulation, diabetes, kidney, and cardiovascular disease. The company also provides ready-to-use enzyme-linked immunosorbent assay (ELISA) kits to quantify NGAL in urine, plasma, and serum; and generic Rapid Assay Device (gRAD) for custom lateral flow assays. BioPorto A/S was founded in 1917 and is based in Hellerup, Denmark.

Compare BIOPOR to Peers and Sector

Metrics to compare
BIOPOR
Peers
Sector
Relationship
P/E Ratio
−7.2x−2.2x−0.5x
PEG Ratio
0.21−0.060.00
Price/Book
14.3x1.5x2.6x
Price / LTM Sales
17.2x7.5x3.3x
Upside (Analyst Target)
207.7%394.7%43.4%
Fair Value Upside
Unlock20.2%7.1%Unlock

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 4.000
(+207.69% Upside)

Earnings

Latest Release
May 08, 2025
EPS / Forecast
-0.06 / -0.05
Revenue / Forecast
7.67M / 11.80M
EPS Revisions
Last 90 days

BIOPOR Income Statement

FAQ

What Stock Exchange Does BioPorto Trade On?

BioPorto is listed and trades on the Copenhagen Stock Exchange stock exchange.

What Is the Stock Symbol for BioPorto?

The stock symbol for BioPorto is "BIOPOR."

What Is the BioPorto Market Cap?

As of today, BioPorto market cap is 591.05M.

What Is BioPorto's Earnings Per Share (TTM)?

The BioPorto EPS (TTM) is -0.20.

When Is the Next BioPorto Earnings Date?

BioPorto will release its next earnings report on 14 Aug 2025.

From a Technical Analysis Perspective, Is BIOPOR a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has BioPorto Stock Split?

BioPorto has split 3 times.

How Many Employees Does BioPorto Have?

BioPorto has 48 employees.

What is the current trading status of BioPorto (BIOPOR)?

As of 10 Aug 2025, BioPorto (BIOPOR) is trading at a price of 1.30, with a previous close of 1.31. The stock has fluctuated within a day range of 1.29 to 1.34, while its 52-week range spans from 1.20 to 2.50.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.